Allen David
Consultant Eye Surgeon, Sunderland Eye Infirmary, Sunderland, UK.
BMJ Clin Evid. 2011 Feb 15;2011:0708.
Cataract accounts for over 47% of blindness worldwide, causing blindness in about 17.3 million people in 1990. Surgery for cataract in people with glaucoma may affect glaucoma control.
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of surgery for age-related cataract without other ocular comorbidity? What are the effects of treatment for age-related cataract in people with glaucoma? What are the effects of surgical treatments for age-related cataract in people with diabetic retinopathy? What are the effects of surgical treatments for age-related cataract in people with chronic uveitis? We searched: Medline, Embase, The Cochrane Library, and other important databases up to May 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
We found 20 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
In this systematic review we present information relating to the effectiveness and safety of the following interventions: for people with cataract without other ocular co-morbidity: cataract surgery alone, cataract surgery with non-concomitant glaucoma surgery, concomitant cataract and glaucoma surgery, intracapsular extraction, manual (large or small) incision extracapsular extraction, and phaco extracapsular extraction; for people with cataract with co-morbid diabetic retinopathy: cataract surgery alone, and adding diabetic retinopathy treatment to cataract surgery; for people with cataract and co-morbid chronic uveitis: cataract surgery, and medical control of uveitis at the time of cataract surgery.
白内障占全球失明病例的47%以上,1990年约导致1730万人失明。青光眼患者的白内障手术可能会影响青光眼的控制。
我们进行了一项系统评价,旨在回答以下临床问题:无其他眼部合并症的年龄相关性白内障手术的效果如何?青光眼患者年龄相关性白内障治疗的效果如何?糖尿病视网膜病变患者年龄相关性白内障手术治疗的效果如何?慢性葡萄膜炎患者年龄相关性白内障手术治疗的效果如何?我们检索了:截至2010年5月的医学期刊数据库(Medline)、荷兰医学文摘数据库(Embase)、考克兰图书馆以及其他重要数据库(临床证据综述会定期更新;请查看我们的网站获取本综述的最新版本)。我们纳入了来自美国食品药品监督管理局(FDA)和英国药品和医疗产品监管局(MHRA)等相关机构的危害警示。
我们找到了20项符合我们纳入标准的系统评价、随机对照试验或观察性研究。我们对干预措施的证据质量进行了GRADE评估。
在本系统评价中,我们提供了以下干预措施有效性和安全性的相关信息:对于无其他眼部合并症的白内障患者:单纯白内障手术、非同期青光眼手术的白内障手术、同期白内障和青光眼手术、囊内摘除术、手法(大切口或小切口)囊外摘除术以及超声乳化囊外摘除术;对于合并糖尿病视网膜病变的白内障患者:单纯白内障手术,以及在白内障手术中增加糖尿病视网膜病变治疗;对于合并慢性葡萄膜炎的白内障患者:白内障手术,以及在白内障手术时对葡萄膜炎进行药物控制。